According to a recent LinkedIn post from Cohere Health, the company is drawing attention to upcoming AHIP requirements that, by 2027, 80% of electronic prior authorization, or ePA, requests should receive real-time answers. The post emphasizes that simply maximizing automation volume may be insufficient without incorporating clinical intelligence into workflows.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights a distinction between automating the most cases and automating the right cases, suggesting that unselective automation could amount to “rubber-stamping” decisions. The post argues that payers should begin laying the groundwork now to build automation programs that balance efficiency with clinically sound decision-making.
For investors, the message suggests Cohere Health is positioning its solutions around clinically informed automation rather than generic process automation to address the 2027 AHIP mandate. This positioning could enhance the firm’s value proposition to health plans seeking compliance while managing clinical risk and may influence adoption rates, pricing power, and competitive differentiation in the healthcare technology segment.